Plain-English translation of NCT05828719 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether a minimally invasive heart procedure—where doctors thread a catheter to open blocked arteries and place stents—improves outcomes for people with heart failure caused by reduced blood flow to the heart. Researchers will compare this procedure to optimal medical management (medications and lifestyle changes) to see which approach helps patients live longer and healthier lives.
Earlier studies show mixed results: bypass surgery improved long-term outcomes, but catheter-based procedures alone haven't consistently helped in stable heart disease. This trial investigates whether using advanced imaging and pressure measurements during the procedure—to place stents more precisely—might finally make a real difference for people with severely weakened hearts.
You likely qualify if…
You likely don't qualify if…
If you are randomized to the medication group, you will receive guideline-based heart failure treatment with regular follow-up visits. If randomized to the procedure group, you will undergo a catheter-based intervention within 2 weeks to open blocked arteries, guided by advanced imaging and blood-flow measurements, followed by medical management and ongoing follow-up. Both groups will be monitored for clinical outcomes over time to see which approach works better.
AI-generated summary from trial data · Aug 15, 2026 · Not medical advice
South Korea